Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000078681 | SCV000110541 | benign | not specified | 2013-10-24 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000078681 | SCV000151850 | benign | not specified | 2016-08-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002313748 | SCV000847851 | benign | Inborn genetic diseases | 2016-08-31 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000974377 | SCV001122198 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000974377 | SCV001902979 | benign | not provided | 2021-05-04 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002490679 | SCV002795003 | likely benign | X-linked Opitz G/BBB syndrome | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000974377 | SCV005279127 | benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003905042 | SCV004724240 | benign | MID1-related disorder | 2019-03-27 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |